Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
Shi Y, Li J, Chen H, Hu Y, Tang L, Wang Y, Zang X, Ma X, Huang G, Zhou X, Tao M, Lv Z, Chen S, Qiu A, Zhuang S, Liu N.
Shi Y, et al. Among authors: hu y.
J Pathol. 2022 Oct;258(2):164-178. doi: 10.1002/path.5987. Epub 2022 Aug 16.
J Pathol. 2022.
PMID: 35792675